Guardian Pharmacy Services (GRDN) Competitors $25.44 -0.78 (-2.96%) As of 12:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRDN vs. FCFS, BOOT, BBWI, RUSHB, ASO, TBBB, CSAN, VSCO, SVV, and CWHShould you be buying Guardian Pharmacy Services stock or one of its competitors? The main competitors of Guardian Pharmacy Services include FirstCash (FCFS), Boot Barn (BOOT), Bath & Body Works (BBWI), Rush Enterprises (RUSHB), Academy Sports and Outdoors (ASO), BBB Foods (TBBB), Cosan (CSAN), Victoria's Secret & Co. (VSCO), Savers Value Village (SVV), and Camping World (CWH). These companies are all part of the "retail" industry. Guardian Pharmacy Services vs. Its Competitors FirstCash Boot Barn Bath & Body Works Rush Enterprises Academy Sports and Outdoors BBB Foods Cosan Victoria's Secret & Co. Savers Value Village Camping World Guardian Pharmacy Services (NYSE:GRDN) and FirstCash (NASDAQ:FCFS) are both retail companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk. Is GRDN or FCFS more profitable? FirstCash has a net margin of 8.61% compared to Guardian Pharmacy Services' net margin of -6.90%. FirstCash's return on equity of 16.63% beat Guardian Pharmacy Services' return on equity.Company Net Margins Return on Equity Return on Assets Guardian Pharmacy Services-6.90% -52.41% -24.17% FirstCash 8.61%16.63%7.70% Do institutionals & insiders have more ownership in GRDN or FCFS? 80.3% of FirstCash shares are owned by institutional investors. 63.7% of Guardian Pharmacy Services shares are owned by company insiders. Comparatively, 2.9% of FirstCash shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor GRDN or FCFS? In the previous week, FirstCash had 8 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 8 mentions for FirstCash and 0 mentions for Guardian Pharmacy Services. FirstCash's average media sentiment score of 1.38 beat Guardian Pharmacy Services' score of 0.00 indicating that FirstCash is being referred to more favorably in the news media. Company Overall Sentiment Guardian Pharmacy Services Neutral FirstCash Positive Do analysts recommend GRDN or FCFS? Guardian Pharmacy Services currently has a consensus target price of $25.67, indicating a potential upside of 0.91%. FirstCash has a consensus target price of $143.00, indicating a potential downside of 5.38%. Given Guardian Pharmacy Services' higher possible upside, equities research analysts clearly believe Guardian Pharmacy Services is more favorable than FirstCash.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardian Pharmacy Services 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00FirstCash 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, GRDN or FCFS? FirstCash has higher revenue and earnings than Guardian Pharmacy Services. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than FirstCash, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardian Pharmacy Services$1.33B1.21-$87.29M-$1.52-16.73FirstCash$3.39B1.98$258.82M$6.5123.22 SummaryFirstCash beats Guardian Pharmacy Services on 12 of the 14 factors compared between the two stocks. Get Guardian Pharmacy Services News Delivered to You Automatically Sign up to receive the latest news and ratings for GRDN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRDN vs. The Competition Export to ExcelMetricGuardian Pharmacy ServicesMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.61B$2.51B$5.65B$21.37BDividend YieldN/A56.32%5.68%3.52%P/E Ratio-16.7523.2775.6629.18Price / Sales1.21570.93521.0082.91Price / Cash102.87174.1537.5624.47Price / Book10.735.1712.994.53Net Income-$87.29M$32.95M$3.29B$1.00B7 Day Performance-3.47%0.77%-0.03%-1.09%1 Month Performance-2.94%5.77%4.13%2.27%1 Year PerformanceN/A1.81%69.08%14.08% Guardian Pharmacy Services Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRDNGuardian Pharmacy Services0.4859 of 5 stars$25.44-3.0%$25.67+0.9%N/A$1.61B$1.33B-16.753,400FCFSFirstCash4.7865 of 5 stars$146.76-0.1%$143.00-2.6%+30.5%$6.51B$3.39B22.5420,000Positive NewsBOOTBoot Barn3.8159 of 5 stars$179.15-1.3%$182.54+1.9%+1.1%$5.48B$1.99B28.2710,400BBWIBath & Body Works4.8587 of 5 stars$26.09-1.4%$39.69+52.2%-11.0%$5.38B$7.31B7.7459,210Options VolumeRUSHBRush Enterprises1.036 of 5 stars$59.05+0.9%N/A+22.2%$4.60B$7.80B16.838,040ASOAcademy Sports and Outdoors3.8951 of 5 stars$46.52+0.1%$58.78+26.4%-21.3%$3.10B$5.97B8.7322,000Positive NewsAnalyst ForecastTBBBBBB Foods2.6803 of 5 stars$26.12-0.1%$33.75+29.2%-17.9%$2.98B$67.08B-326.4425,300CSANCosan4.8761 of 5 stars$5.77+2.6%$12.00+108.2%-46.4%$2.69B$8.15B4.3712,090Analyst UpgradeVSCOVictoria's Secret & Co.3.0866 of 5 stars$26.41-4.7%$26.27-0.5%-5.0%$2.12B$6.23B14.6731,000SVVSavers Value Village1.9458 of 5 stars$12.90+1.3%$12.20-5.4%+25.4%$2.01B$1.58B61.4822,700CWHCamping World3.8267 of 5 stars$17.22+0.8%$21.78+26.5%-30.0%$1.76B$6.10B-86.2013,060Positive News Related Companies and Tools Related Companies FirstCash Alternatives Boot Barn Alternatives Bath & Body Works Alternatives Rush Enterprises Alternatives Academy Sports and Outdoors Alternatives BBB Foods Alternatives Cosan Alternatives Victoria's Secret & Co. Alternatives Savers Value Village Alternatives Camping World Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GRDN) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
